A recent study found that Black patients with ovarian cancer continue to have worse survival outcomes, but the data suggests that adherence to treatment guidelines may not be the cause. This research was presented during the ASCO 2021 Annual Meeting (Abstract 5552). “Racial disparities exist in outcomes for many cancers, but ovarian cancer is one of the most striking,” noted study author Deanna Huffman, DO, of Allegheny Health Network. “It is important for us to direct research at why these disparities continue to exist so they can be appropriately addressed. “Past data has told us that Black patients may not be getting the same standard-of-care treatment as White patients, but we wanted to further investigate this theory using the most up-to-date survival data from the National Cancer Database,” she continued.
Radiation Oncologists Met With Congressional Leaders to Reverse CMS Cuts and Provide Equal Access to Care
Radiation oncologists met with Congress to urge leaders to consider how the Medicare and Medicaid Services (CMS) proposal to make significant cuts to radiation oncology facilities could be detrimental to the survival of patients with Read more…
FDA Approves Neoadjuvant Pembrolizumab Combination for Early TNBC Indication
The FDA granted approval to the supplemental biologics license application (sBLA) for pembrolizumab (Keytruda) as neoadjuvant therapy for patients with high-risk early-stage triple-negative breast cancer (TNBC) when given in combination with chemotherapy followed by single-agent Read more…
Recommended TVUS Screening Thresholds May Miss Endometrial Cancer in Black Women
Adherence to current clinical guidelines for the evaluation of postmenopausal bleeding may result in systematic underdiagnosis of endometrial cancer (EC) in Black women, according to a study published online July 15 in JAMA Oncology. Kemi M. Read more…